Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables

Value{"unit": "CHF", "value": 254438}
Period2020-01-01 – 2020-12-31
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-21-018959
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/a5fe58b9-8731-4e9c-b5c6-3dd59150c5ac

History